Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.9922
-0.0378 (-3.67%)
At close: Sep 26, 2025, 4:00 PM EDT
0.9930
+0.0008 (0.08%)
After-hours: Sep 26, 2025, 7:48 PM EDT
Elutia Market Cap
Elutia has a market cap or net worth of $42.06 million as of September 26, 2025. Its market cap has decreased by -71.54% in one year.
Market Cap
42.06M
Enterprise Value
61.81M
1-Year Change
-71.54%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $42.06M, a decrease of -75.80%. That is a compound annual growth rate of -24.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 42.06M | -67.46% |
| Dec 31, 2024 | 129.26M | 157.97% |
| Dec 29, 2023 | 50.11M | -26.88% |
| Dec 30, 2022 | 68.53M | -19.77% |
| Dec 31, 2021 | 85.42M | -38.72% |
| Dec 31, 2020 | 139.38M | -19.82% |
| Oct 8, 2020 | 173.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |